Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone.

Journal: Journal of the Endocrine Society
Published Date: Jul 21, 2017

Abstract

PURPOSE: Intramuscular (IM) testosterone is the most common modality for testosterone therapy of both male hypogonadism and female-to-male (FTM) gender transition. However, IM injections can be painful and often are not self-administered by the patient. The objective of this study was to further characterize subcutaneous (SC) administration of testosterone as an effective and safe alternative to IM injections by evaluating the pharmacodynamics of serum total and free testosterone concentrations between weekly testosterone injections.

Authors

  • Julie McFarland
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Maine Medical Center, Portland, Maine 04102.
  • Wendy Craig
    Maine Medical Center Research Institute, Scarborough, Maine 04074.
  • Nigel J Clarke
    Quest Diagnostics, Valencia, California 91355.
  • Daniel I Spratt
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Maine Medical Center, Portland, Maine 04102.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals